Detalhe da pesquisa
1.
Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II study.
Invest New Drugs
; 37(2): 345-351, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30610588
2.
Outcomes of children exposed in utero to chemotherapy for breast cancer.
Breast Cancer Res
; 16(6): 500, 2014 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-25547133